Krishna Yeshwant, Director, 10% Owner at Verve Therapeutics, Inc. (VERV), bought 1,800,000 shares at $10.00 ($18.0M) on 2023-12-01, disclosed to the SEC on 2023-12-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| VERV | SELL | 2022-11-02 | $6.5M | — | Filing → |
| FMI | SELL | 2017-08-10 | $192K | — | Filing → |
| FMI | SELL | 2017-08-08 | $1.3M | — | Filing → |